Brigatinib treated ALK positive lung squamous cell carcinoma after failed chemotherapy: A case report

被引：0
作者：
Li, Shuluan [1 ,2 ]
Zhang, Pei [3 ]
Wang, Tianyu [2 ,4 ]
Wang, Jie [3 ]
Duan, Jianchun [3 ]
机构：
[1] Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Clin Res Ctr Canc, Dept Med Oncol Natl,Canc Ctr, Shenzhen 100021, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Shenzhen Hosp, Shenzhen, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Clin Res Ctr Canc, Dept Med Oncol,Natl Canc Ctr, Beijing 100021, Peoples R China
[4] Chinese Acad Med Sci & Peking Union Med Coll, Dept Breast Surg, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Shenzhen, Peoples R China
来源：
THORACIC CANCER | 2021年 / 12卷 / 23期
关键词：
ALK; brigatinib; chemotherapy; lung squamous cell carcinoma; 1ST-LINE CRIZOTINIB; OPEN-LABEL; CANCER; ROS1;
D O I：
10.1111/1759-7714.14133
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The definitive efficacy of anaplastic lymphoma kinase (ALK) inhibitors in ALK positive lung squamous cell carcinoma (sqCC) patients remain unclear. Here, we report a case in which brigatinib had a therapeutic effect on ALK-positive lung squamous cell carcinoma. The patient in this report was diagnosed with ALK-positive lung squamous cell carcinoma with brain metastases, and received brigatinib after failure of first-line chemotherapy. Response duration was approximately 11 months, with tolerable side effects. In conclusion, a good clinical effect was achieved in a patient with ALK positive lung squamous cell carcinoma who received treatment with an ALK inhibitor.
引用
收藏
页码：3273 / 3276
页数：4
相关论文
共 50 条
  • [21] Transformation of SCLC to Lung Squamous Cell Carcinoma after First-Line Chemotherapy and Response to Sintilimab: A Case Report
    Liu, Z.
    Zhang, J.
    Huang, M.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S536 - S536
  • [22] A case report of complete pathological remission after chemotherapy in a patient with primary renal squamous cell carcinoma
    Yu, Haiming
    Yu, Lan
    Li, Jinying
    Wang, Yu
    Liu, Li
    Zhang, Xiaotao
    Han, Xiaona
    Cheng, Xi
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2021, 10 (02) : 997 - 1005
  • [23] ALK-rearranged squamous cell carcinoma of the lung
    Takanashi, Yusuke
    Tajima, Shogo
    Matsuura, Shun
    Koyama, Shin
    Takahashi, Tsuyoshi
    Neyatani, Hiroshi
    RESPIROLOGY CASE REPORTS, 2015, 3 (03): : 105 - 107
  • [24] ALK-rearranged squamous cell carcinoma of the lung
    Meng, Qiyi
    Dong, Yujie
    Tao, Hong
    Shi, Liang
    Tong, Li
    Tang, Junfang
    Zhang, Shucai
    Liu, Zhe
    THORACIC CANCER, 2021, 12 (07) : 1106 - 1114
  • [25] Gene profiling of metastatic small intestinal squamous cell carcinoma after lung squamous cell carcinoma surgery: a case report
    Zhu, Fangchao
    Lin, Jiejun
    Liao, Hongli
    Wang, Yunfei
    Pan, Jie
    TRANSLATIONAL CANCER RESEARCH, 2022, 11 (04) : 967 - 972
  • [26] Extraordinary response to crizotinib in a woman with squamous cell lung cancer after two courses of failed chemotherapy
    Wang, Qiushi
    He, Yong
    Yang, Xin
    Wang, Yubo
    Xiao, Hualiang
    BMC PULMONARY MEDICINE, 2014, 14
  • [27] Colonic metastasis after resection of primary squamous cell carcinoma of the lung: A case report and literature review
    Lou, Hai-Zhou
    Wang, Chun-Hua
    Pan, Hong-Ming
    Pan, Qin
    Wang, Jin
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (19) : 5930 - 5934
  • [28] Successful intracranial response of lorlatinib after resistance with alectinib and brigatinib in patients with ALK-positive lung adenocarcinoma: Implications of CNS penetration rate of brigatinib
    Sato, Yuki
    Sato, Yoshiharu
    Irie, Kei
    Nanjo, Shigeki
    Hara, Shigeo
    Fujiwara, Satoru
    Tomii, Keisuke
    THORACIC CANCER, 2024, 15 (23) : 1772 - 1775
  • [29] Histologic transformation of lung adenocarcinoma to squamous cell carcinoma after chemotherapy: two case reports
    Shao, Yi
    Zhong, Dian-Sheng
    Guan, Sha-Sha
    TRANSLATIONAL CANCER RESEARCH, 2020, 9 (01) : 388 - 393
  • [30] Transformation of Lung Squamous Cell Carcinoma to Small Cell Lung Cancer After Immunotherapy Resistance: A Case Report
    Wang, Diming
    Ye, Wei
    Chen, Dongmei
    Shi, Qingming
    Ma, Dongchun
    CANCER MANAGEMENT AND RESEARCH, 2023, 15 : 803 - 808
12345